Skip to content

Common Stock at other companies

Incyte logo
IncyteINCY
400M0.0%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
500M0.0%
UroGen Pharma logo
UroGen PharmaURGN
$134K+6.3%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
500M+253,707%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$5K+25.0%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$9K0.0%

Other financials

Income statement

See full
Operating income-$42.0M-31.9%
Net income-$39.3M-39.6%
EPS (diluted)-$0.64-36.2%

Balance sheet

See full
Cash & equivalents$85.0M-15.7%
Total debt$5.7M-6.9%
Total equity$387.6M+19.8%
Total assets$412.0M+20.0%

Cash flow

See full
Operating cash flow-$32.6M-27.9%
CapEx$88.0K+529%
Free cash flow-$32.7M-28.2%

Valuation

See full
Market cap$1.81B+318%
Enterprise value$1.73B+397%

Returns & leverage

See full
Return on equity-36.9%+21.1pp
Debt / equity0.0×
Current ratio20.5×-2.3×

Where this comes from

Reported directly by Tyra Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tyra Biosciences, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tyra Biosciences, Inc.'s common stock?
Tyra Biosciences, Inc. (TYRA) reported common stock of $6K in Q1 2026.
How has Tyra Biosciences, Inc.'s common stock changed year-over-year?
Tyra Biosciences, Inc.'s common stock increased by 20.0% year-over-year, from $5K to $6K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).